Capricor Therapeutics https://www.biospace.com/employer/399127/capricor-therapeutics Capricor Therapeutics en-US Tue, 25 Aug 2020 12:53:46 GMT Biopharma Update on the Novel Coronavirus: August 26 https://www.biospace.com/biopharma-update-on-the-novel-coronavirus-august-26 BioSpace Editorial Staff Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 26, 2020. Tue, 25 Aug 2020 12:53:46 GMT https://www.biospace.com/biopharma-update-on-the-novel-coronavirus-august-26 SoCal's Capricor to Reduce Workforce and Shift Focus After Discouraging Trial Results https://www.biospace.com/socal-s-capricor-to-reduce-workforce-and-shift-focus-after-discouraging-trial-results Fri, 12 May 2017 15:09:04 GMT https://www.biospace.com/socal-s-capricor-to-reduce-workforce-and-shift-focus-after-discouraging-trial-results BioSpace Movers & Shakers: New Appointments for Maraganore, Afeyan https://www.biospace.com/biospace-movers-and-shakers-may-27 Alex Keown Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers. Thu, 26 May 2022 17:54:23 GMT https://www.biospace.com/biospace-movers-and-shakers-may-27 Research Roundup: Getting the Inner Ear to Regenerate and More https://www.biospace.com/research-roundup-getting-the-inner-ear-to-regenerate-and-more Mark Terry Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones. Thu, 05 Aug 2021 13:35:38 GMT https://www.biospace.com/research-roundup-getting-the-inner-ear-to-regenerate-and-more Capricor Falls as Johnson & Johnson Bails on Stem Cell Heart Med https://www.biospace.com/capricor-falls-as-johnson-and-johnson-bails-on-stem-cell-heart-med Fri, 07 Jul 2017 14:50:30 GMT https://www.biospace.com/capricor-falls-as-johnson-and-johnson-bails-on-stem-cell-heart-med New Capricor Data Signals Hope for Difficult-to-Treat Duchenne Muscular Dystrophy Population https://www.biospace.com/new-capricor-data-signals-hope-for-difficult-to-treat-dmd-population Heather McKenzie Capricor announced positive final data from the HOPE-2 trial of its drug candidate. It showed a slowing of disease progression in Duchenne muscular dystrophy patients. Fri, 24 Sep 2021 14:46:25 GMT https://www.biospace.com/new-capricor-data-signals-hope-for-difficult-to-treat-dmd-population Capricor Ditches COVID-19 Vaccine Program to Focus on DMD https://www.biospace.com/capricor-ditches-covid-19-vaccine-program-to-focus-on-duschenne-muscular-dystrophy-program Hannah Chudleigh Capricor Therapeutics announced less-than-stellar Q4 2021 and full-year 2021 financial results and said the company stopped efforts on its COVID-19 vaccine. Fri, 11 Mar 2022 15:00:15 GMT https://www.biospace.com/capricor-ditches-covid-19-vaccine-program-to-focus-on-duschenne-muscular-dystrophy-program 5 DMD Data Readouts to Watch in 2024 https://www.biospace.com/5-dmd-data-readouts-to-watch-in-2024 Heather McKenzie With three FDA approvals in the past 10 months, there is a lot of momentum in the Duchenne muscular dystrophy space. Here are five companies looking to keep it going. Wed, 01 May 2024 14:40:38 GMT https://www.biospace.com/5-dmd-data-readouts-to-watch-in-2024 Biopharma Update on the Novel Coronavirus: April 3 https://www.biospace.com/biopharma-update-on-the-novel-coronavirus-april-3 BioSpace Editorial Staff Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 3, 2020. Fri, 03 Apr 2020 12:28:11 GMT https://www.biospace.com/biopharma-update-on-the-novel-coronavirus-april-3 Biopharma Update on the Novel Coronavirus: April 29 https://www.biospace.com/biopharma-update-on-the-novel-coronavirus-april-29 BioSpace Editorial Staff Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 29, 2020. Wed, 29 Apr 2020 12:24:38 GMT https://www.biospace.com/biopharma-update-on-the-novel-coronavirus-april-29